{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
NCT04470427: Phase 3 Interventional Completed SARS-CoV-2
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01191372: Phase 1 Interventional Terminated Hemophilia
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
BLA125796
(2024)
Source URL:
First approved in 2024
Source:
BLA125796
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
Moderna COVID-19 Vaccine by Moderna US, Inc.
(2023)
Source URL:
First approved in 2023
Source:
Moderna COVID-19 Vaccine by Moderna US, Inc.
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
BLA125752
(2022)
Source URL:
First approved in 2022
Source:
BLA125752
Source URL:
Class:
NUCLEIC ACID